Myovant Sciences Ltd. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 5 rows, 5 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-03-10: Reporting owner Merendino Lauren; Form 4; Security Performance Stock Unit; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2023-03-10: Reporting owner Mehra Uneek; Form 4; Security Performance Stock Unit; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2023-03-10: Reporting owner Marek David C; Form 4; Security Performance Stock Unit; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2023-03-10: Reporting owner Lang Matthew; Form 4; Security Performance Stock Unit; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-03-10 | Merendino Lauren Officer (Chief Commercial Officer) | 4 | Performance Stock Unit Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −103,703 0 owned after | no price filed | 2023-03-10 | |
| 2023-03-10 | Mehra Uneek Officer (Principal Financial Officer) | 4 | Performance Stock Unit Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −111,111 0 owned after | no price filed | 2023-03-10 | |
| 2023-03-10 | Marek David C Director, Officer (Principal Executive Officer) | 4 | Performance Stock Unit Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −134,567 0 owned after | no price filed | 2023-03-10 | |
| 2023-03-10 | Lang Matthew Officer (General Counsel & Corp. Secy.) | 4 | Performance Stock Unit Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −111,111 0 owned after | no price filed | 2023-03-10 | |
| 2023-03-10 | Arjona Ferreira Juan Camilo Officer (Chief Medical Officer) | 4 | Performance Stock Unit Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −103,703 0 owned after | no price filed | 2023-03-10 |